- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1755-8794
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Network analysis of atherosclerotic genes elucidates druggable targets ; volume:15 ; number:1 ; day:3 ; month:3 ; year:2022 ; pages:1-12 ; date:12.2022
BMC medical genomics ; 15, Heft 1 (3.3.2022), 1-12, 12.2022
- Creator
-
Banik, Sheuli Kangsa
Baishya, Somorita
Talukdar, Anupam Das
Choudhury, Manabendra Dutta
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12920-022-01195-y
- URN
-
urn:nbn:de:101:1-2022060214101594036566
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
01.08.2025, 1:01 PM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Banik, Sheuli Kangsa
- Baishya, Somorita
- Talukdar, Anupam Das
- Choudhury, Manabendra Dutta
- SpringerLink (Online service)
Other Objects (12)
Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
Cysteine metabolic circuitries: druggable targets in cancer
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
Cysteine metabolic circuitries: druggable targets in cancer
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study
Author Correction: NMNAT2 is a druggable target to drive neuronal NAD production
Network analysis of coronary artery disease risk genes elucidates disease mechanisms and druggable targets
Identifying therapeutic target genes for migraine by systematic druggable genome-wide Mendelian randomization
Cysteine metabolic circuitries: druggable targets in cancer
Systematic Mendelian Randomization Exploring Druggable Genes for Hemorrhagic Strokes
In search of druggable targets for GBM amino acid metabolism
NMNAT2 is a druggable target to drive neuronal NAD production
Identifying potential drug targets for idiopathic pulmonary fibrosis: a mendelian randomization study based on the druggable genes
Verification of EZH2 as a druggable target in metastatic uveal melanoma
Gli1/DNA interaction is a druggable target for Hedgehog‐dependent tumors
Systematic druggable genome-wide Mendelian randomization identifies therapeutic targets for lung cancer
Druggable targets for Parkinson’s disease: transcriptomics based Mendelian randomization study